Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Ab Stock Analysis Alliancebernstein Holding L.P. Units Up 1.68 Pct To 38.63 Usd On Positive Sector Momentum 20260403 1 Vanguard SP 500 ETF VOO Strategic CrossAsset Allocation Play Amid Divergent Equity and Crypto Performance Exxon Mobil Corporation XOM MajorityOwned Imperial Oil Delivers Resilient Q1 2026 Results Affirms Shareholder Return Policy What SCWorx WORX is doing that smart investors recognize Risk Aversion 20260506 How Eaton EIM competitive position is evolving Motionless 20260508 Republic Services RSG Stock Analysis 058 Loss Key Levels 20260521 Walmart Stock Declines Following Cautious Guidance Amid Elevated Gas Prices ECBs Rehn Signals Limited Evidence of Sustained High Inflation Pressures MapLight Therapeutics MPLT Q1 2026 Stumbles EPS 134 Misses Target VolitionRx Limited VNRX Highlighted Among TopRated Penny Stocks by Wall Street Analysts Why the US 10Year Bond Yield Matters More Than Most Investors Realise AI Accelerates Drug Discovery for Brain Disorders Researchers Suggest OpenAI Moves to Lead AI IPO Race Amid Reports of Confidential Filing Nvidia Stock Approaches Critical Technical Level Amid AI Sector Momentum ixigo Partners with Uber and redBus to Enhance Train Travel Experience with Integrated Cab and Bus Bookings SOHOB Q2 2025 Earnings Preferred Dividend Coverage Maintained with Reported EPS of 021 AMCR Q1 2026 Earnings EPS Misses Estimates Shares Edge Lower PRLD Q1 2026 Earnings NarrowerThanExpected Loss as Clinical Pipeline Advances ADUS Q1 2026 Earnings EPS Beat Driven by Strong Operational Execution MZTI Q1 2026 Earnings EPS Falls 16 Short of Estimates Stock Edges Lower Ralliant Corporation RAL Q1 2026 Earnings EPS Beats Estimates by 1531 ServiceNow Inc NOW Rises 189 as Stock Approaches Key Resistance WHLRD Preferred Shares Hold Steady at 3900 Amid Narrow Trading Range Apollo Global Management APO Slides 126 as Broader Market Pressures Weigh Definium Therapeutics DFTX Gains on Strength Approaching Key Resistance Scinai Immunotherapeutics SCNI Extends Losses as Stock Hovers Near Key Support